References [1] Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. The Lancet Oncology (2003). [2] First-line treatment with bendamustine and rituximab, in patients with ...

The study, titled “Ultrasound neuromodulation of an anti-inflammatory pathway at the spleen produces sustained improvement of experimental pulmonary hypertension,” is the first report of ...

Splenic marginal zone lymphoma (SMZL) is a rare, indolent B-cell lymphoma that principally involves the spleen, often extending to the bone marrow and peripheral blood, while nodal involvement ...